y
|
| Scholar |
|
|
Articles by Mazhar, D.
|
|
Articles bye Ngan, S.
|
|
Search- for Related Content
|
|
| PubMed |
|
|
PubMed Citation
|
|
Articles by Mazhar, D.
|
|
Articles by Ngan, S.
|
|
| Email ocial Bookmarking |
|
|
What's this?
|
Nude
q
© The Author 2006. aublished by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, pleasegemail:j journals.permixions@oxfordjournals.org
C-reactive protein and colorectal cancer
D. Mazhar and
S. Ngan
From the o Departmenteof Oncology, Medical Day Unit, Chelsea andzWestminster Hospital, London, UK
Address correspondence to
r D. Mazhar, Department tf t Oncology, Medical Day Unit, Chelsea and Westminster Hospital, 369jFulham Road, ndon SW10 9NH. email: d.mazhar{}imperial.ac.uk
There is nodoubt that colorectal cancer poses a significant clinical burden. According to Cancer Research UK,_there arce around 35 000 new cases of large-bowel cancer
n the UK annually, making it the second most common malignancy Email in women, andhe third most commonn men. In
02, thereiwere 16 220 deaths from the disease.1 Overall, around 40% of sufferers survive for 5 years. Early diagnosis leads to improved outcomes, and